Skip to main content

View full-text article in PMC

. 2017 Jan 31;17:89. doi: 10.1186/s12885-017-3071-5

Table 2.

Adverse events by grade in this phase-I study

	Level 1				Level 2			Level 3
Patient no.	1	2	3	4	5	6	7	8	9	10	11
Appetite loss	2	2
General fatigue									2
Nausea		2							2
Vomiting		2							2
Ileus		2				3
Constipation	2					2			2
Diarrhea						2
Abdominal pain		2				2
Abdominal fullness	2					3
Intraabdominal bleeding										2
Lumbago						2
Headache						2
Fever						2^c	2^c
Dyspnea									2
Hematoma^a							2
Erythema									2
Anemia	2			2	2	3	2
Elevation of ALT							2
Elevation of CRP			2				2^c	2^c
Hypoalbuminemia	2		2
Hypotension^b								3^c			3^c

^aHematoma in the inserted port

^bTransient hypotension accompanied by abdominal peritoneal irritation

^cAdverse events during the administration of BK-UM

No asterisk in adverse events indicates events monitored during the observation period after the administration of BK-UM